CTNM (NASDAQ: CTNM) insider schedules 4,170-share sale under trading plan

Rhea-AI Filing Summary

An insider of CTNM has filed a notice of intent to sell shares. The filing covers 4,170 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $59,964.60 and 23,099,173 shares outstanding.

The shares were originally acquired as 4,170 restricted stock units from the issuer on May 9, 2017. The same account has sold 4,170 shares on December 23, 2025 for $51,009.11 and another 4,170 shares on January 5, 2026 for $43,543.06 under a Rule 10b5‑1 trading plan for Daniel Lorrain.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4170	59964.60	23099173	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2017	Restricted Stock Units	Issuer			4170	05/09/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	01/05/2026	4170	43543.06
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	12/23/2025	4170	51009.11

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CTNM Form 144 filing disclose about upcoming share sales?

The filing discloses an insider’s intent to sell 4,170 common shares of CTNM. These shares are planned to be sold on February 3, 2026 on NASDAQ, with an indicated aggregate market value of $59,964.60.

How many CTNM shares has the insider recently sold under Rule 10b5-1?

The account for Daniel Lorrain sold 4,170 shares on January 5, 2026 for $43,543.06 and another 4,170 shares on December 23, 2025 for $51,009.11 under a Rule 10b5‑1 plan.

How were the CTNM shares in this Form 144 originally acquired?

The 4,170 CTNM shares covered by the notice were acquired as restricted stock units from the issuer. The acquisition occurred on May 9, 2017, and the issuer is shown as the source of the grant in the filing.

What is the total number of CTNM shares outstanding referenced in the filing?

The filing states that there are 23,099,173 common shares of CTNM outstanding. This figure provides context for the planned sale of 4,170 shares, showing the relative size of the insider’s transaction.

Through which broker will the CTNM insider sale be executed?

The planned sale of 4,170 CTNM shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists its address as 1 New York Plaza, 8th Floor, New York, NY 10004 for executing the NASDAQ transaction.

What representation does the CTNM insider make about non-public information?

By signing the notice, the person for whose account the CTNM shares are sold represents that they do not know any material adverse nonpublic information about the issuer’s current or prospective operations, consistent with Rule 144 and Rule 10b5‑1 requirements.